A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkey.
about
Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity.Sequential immunization with V3 peptides from primary human immunodeficiency virus type 1 produces cross-neutralizing antibodies against primary isolates with a matching narrow-neutralization sequence motif.Anti-V3 humanized antibody KD-247 effectively suppresses ex vivo generation of human immunodeficiency virus type 1 and affords sterile protection of monkeys against a heterologous simian/human immunodeficiency virus infection.Small intestine CD4+ cell reduction and enteropathy in simian/human immunodeficiency virus KS661-infected rhesus macaques in the presence of low viral loadA method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain.Mycobacterium bovis Bacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease ControlSmall intestine CD4+ T cells are profoundly depleted during acute simian-human immunodeficiency virus infection, regardless of viral pathogenicity.Genetic similarity of circulating and small intestinal virus at the end stage of acute pathogenic simian-human immunodeficiency virus infection.A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.Early bone marrow hematopoietic defect in simian/human immunodeficiency virus C2/1-infected macaques and relevance to advance of disease.A highly pathogenic simian/human immunodeficiency virus effectively produces infectious virions compared with a less pathogenic virus in cell culture.Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical modelStrength of envelope protein interaction modulates cytopathicity of measles virus.Identifying viral parameters from in vitro cell cultures.Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys.Early virological events in various tissues of newborn monkeys after intrarectal infection with pathogenic simian human immunodeficiency virus.Induction of CD95 ligand expression on T lymphocytes and B lymphocytes and its contribution to apoptosis of CD95-up-regulated CD4+ T lymphocytes in macaques by infection with a pathogenic simian/human immunodeficiency virus.Protective immune responses induced by a non-pathogenic simian/human immunodeficiency virus (SHIV) against a challenge of a pathogenic SHIV in monkeys.Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
P2860
Q33717525-662E2B46-C1D5-4A4E-BCB2-8F12629273CEQ34045678-043439FC-6116-4B9C-8083-3C0260A0586CQ34227778-86160541-8779-4622-901B-12BB9A9F6B12Q34335096-EB3FE7E9-F73F-45CF-BDDE-F2DE8823622BQ34648342-0C36E624-037E-4D64-B885-673DB7F57B05Q34648429-0633CD39-6236-4A8C-AED9-17F92AEFF744Q35336419-AB090BF6-9A8F-4BE1-90B1-DCA3A7AD5950Q35633691-851D037C-BA0C-4E09-A9D3-C1D7C5E1C1F4Q35909944-58F1D61E-4F67-4915-B9B9-F3CED48B1E30Q36673263-AF93F69C-EE9E-4B50-ADD1-8A8CA47A9ED5Q37030021-63E5433C-4FEF-4214-ADE1-805290693877Q37492797-33E92654-AFD5-4B4C-B39A-AFBA26FCCC92Q37568263-1E13FF30-FDF9-4F91-A564-DD29C4E95079Q38826130-C0738F92-5CFA-4AA8-A7AA-22A77F335BF0Q38936872-715A1B96-D1BE-4BAB-85E9-21C2DF709AFBQ39390501-142E546C-C2D7-44D5-BE1C-37BB5410B74FQ39683453-45859718-F393-4ADA-95AF-C5B40BEE1511Q42322683-94ECCAFA-2F9E-443F-B716-0152DFB3CA7CQ45326424-2E97D948-9B09-48B5-AF3F-BB5883EC44B6Q45398678-80A4631C-D053-4C0B-BD5C-D3DA69C2D43FQ45424291-56A3455A-D47D-45F0-AB3D-F5FAE20416EBQ45739307-7D546840-B4C1-4536-8470-FD78690D03B4Q45741628-7FB1ECFD-5D64-40E9-BBDB-50C3D37D403DQ47411621-A885BA89-BFBA-40D5-A14C-5670C7918704
P2860
A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkey.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
A highly pathogenic simian/hum ...... changes in cynomolgus monkey.
@en
A highly pathogenic simian/hum ...... changes in cynomolgus monkey.
@nl
type
label
A highly pathogenic simian/hum ...... changes in cynomolgus monkey.
@en
A highly pathogenic simian/hum ...... changes in cynomolgus monkey.
@nl
prefLabel
A highly pathogenic simian/hum ...... changes in cynomolgus monkey.
@en
A highly pathogenic simian/hum ...... changes in cynomolgus monkey.
@nl
P2093
P1476
A highly pathogenic simian/hum ...... changes in cynomolgus monkey.
@en
P2093
Nakasone T
Shinohara K
P304
P356
10.1099/0022-1317-80-5-1231
P407
P478
80 ( Pt 5)
P577
1999-05-01T00:00:00Z